ArticleThe Journal of urology2013

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer.

Colin P N Dinney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.